Skip to main content

Table 1 Characteristics of participants with symptomatic knee OA in each cohort at each time point

From: Comparing the functional impact of knee replacements in two cohorts

 

MOST study

OAI study

Baseline (N = 824)

30 month (N = 818)

60 month (N = 765)

Baseline (N = 880)

24 month (N = 793)

48 month (N = 762)

Age, mean (SD), year

66.1 (6.4)

66.6 (6.7)

67.3 (6.8)

66.1 (6.7)

66.3 (6.9)

66.9 (7.1)

N (%) of women

541 (65.7)

527 (64.4)

512 (66.9)

515 (58.5)

486 (61.3)

451 (59.2)

N (%) of race

      

 Whites

679 (82.4)

672 (82.2)

631 (82.5)

633 (71.9)

627 (79.1)

604 (79.3)

 Blacks

137 (16.6)

139 (17.0)

118 (15.4)

219 (24.9)

147 (18.5)

135 (17.7)

 Others

8 (1.0)

7 (0.9)

16 (2.1)

28 (3.2)

19 (2.4)

23 (3.0)

BMI, mean (SD), kg/m2

32.6 (6.6)

32.5 (6.5)

32.9 (6.8)

29.9 (4.7)

30.1 (4.8)

30.4 (4.9)

CES-D, mean (SD)

8.7 (8.5)

8.0 (7.6)

7.8 (7.6)

7.1 (6.9)

6.9 (7.3)

7.5 (7.5)

Charlson comorbidity score, mean (SD)

0.7 (1.0)

0.8 (1.2)

0.9 (1.4)

0.5 (0. 9)

0.6 (1.0)

0.5 (1.0)

# of painful joints in lower limb other than knee, mean (SD)

2.0 (1.9)

1.4 (1.7)

1.9 (1.8)

1.0 (1.4)

0.9 (1.3)

0.9 (1.3)

N (%) with KR

      

 Unilateral KR

77 (9.3)

139 (17.0)

167 (21.8)

57 (6.5)

88 (11.1)

123 (16.1)

 Bilateral KR

0 (0)

29 (3.6)

101 (13.2)

0 (0)

4 (0.5)

19 (2.5)

N (%) with partial and total KR

      

 Partial KR

3 (0.4)

9 (1.1)

10 (1.3)

0 (0.00)

0 (0.00)

2 (0.3)

 Total KR

74 (9.0)

158 (19.3)

257 (23.6)

57 (6.5)

92 (11.6)

139 (18.2)

 Partial KR and total KR

0 (0)

1 (0.1)

1 (0.1)

0 (0)

0 (0)

0 (0)

WOMAC function, mean (SD)

24.3 (11.7)

23.0 (12.5)

19.0 (12.2)

19.6 (12.6)

17.5 (12.4)

17.0 (11.9)

Maximal WOMAC knee pain scale, mean (SD)

7.3 (3.7)

6.8 (3.9)

5.6 (3. 9)

6 (3.9)

5.6 (3.8)

5.5 (3.7)